Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STRL vs GSK✓SelectedUSD · GSKSTRL vs GSK performance historyLatest closeAs of+0.05%11/17
Stock and ETF performance explorer

STRL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-17.3%
GSK return
+7.1%
Excess return
-24.4%
Maximum drawdown
-75.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-2.3%+2.4%-1.1%
7D-4.9%-3.0%-1.9%-6.3%
30D-35.1%+0.4%-35.5%-34.2%
3M-54.4%-1.2%-53.2%-53.5%
6M-67.6%+0.9%-68.5%-67.2%
YTD-10.1%+4.0%-14.1%-4.6%
1Y-17.3%+7.3%-24.6%-13.7%
All-17.3%+7.1%-24.4%-13.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling